Three HZB teams have managed to increase the efficiency of perovskite silicon tandem solar cells to a new record value of 29.80 %. This brings the 30 percent mark within reach. Get more information on this scientific highlight here
World record again at HZB
Battery research at HZB
More than just a job
Physicist Annette Pietzsch develops instruments that enable researchers at BESSY II to observe how molecules react with each other. "We study the fundamental phenomena of our world here," she says. Find out how to master challenges in everyday life and why researchers sometimes need a bit of frustration tolerance. Click here for her portrait.
Green hydrogen for the energy transition
CatLab in Berlin will become a beacon for research on catalyst materials. Such materials are needed to produce green hydrogen with renewable energy such as sunlight or wind power. Green Hydrogen is considered a building block in a future climate-neutral energy supply. Climate protection and sustainability also played a major role in the architectural competition.
How does BESSY II contribute to the research on SARS-CoV-2?
At the light source BESSY II, researchers gain important insights into the corona virus. How do they do that? Our expert Manfred Weiss explains on the HZB YouTube channel how protein crystallography works. All important information about the SARS-CoV-2 research at BESSY II can be found here.
The route to BESSY III
At HZB we have the experts for designing and building a new accelerator source, and we have many creative scientists onboard, who are making advancements in the development of photon research. The new source BESSY III is planned go into operation in 2030. Our aim is to offer worldwide unique experiments that will accelerate the gaining of new insights in many disciplines.
Patients with eye tumours are being treated with proton beams since June 1998 by the Charité Universitätsklinikum Benjamin Franklin together with the Helmholtz-Zentrum Berlin. Especially, we succeed to destroy the tumour in more than 97 percent of the patients. Eye tumour therapy with protons